Prenetics Global Limited (PRE)

HK — Healthcare Sector
Peers: SHC  BNR  STIM  RNR  EG  AXS  ACGL 

Automate Your Wheel Strategy on PRE

With Tiblio's Option Bot, you can configure your own wheel strategy including PRE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PRE
  • Rev/Share 3.1931
  • Book/Share 12.3907
  • PB 0.6514
  • Debt/Equity 0.032
  • CurrentRatio 2.0698
  • ROIC -0.2559

 

  • MktCap 105053879.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -2.1777
  • Debt/Assets 0.0252
  • DivYield 0
  • ROE -0.2757

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Prenetics Global Limited (PRE)

  • IPO Date 2021-07-16
  • Website https://www.prenetics.com
  • Industry Medical - Diagnostics & Research
  • CEO Sheng Wu Yeung
  • Employees 285
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.